Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
The highest attrition rates during drug development programs occur at the proof of concept stage. Given the large number of molecules under development for Crohn's disease, a need exists to improve the efficiency of early drug development by fast-tracking promising agents and terminating ineffe...
Những tác giả chính: | Jairath, V, Levesque, B, Vande Casteele, N, Khanna, R, Mosli, M, Hindryckx, P, Travis, S, Duijvenstein, M, Rimola, J, Panes, J, D'Haens, G, Sandborn, W, Feagan, B |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Oxford University Press
2016
|
Những quyển sách tương tự
-
Evolving concepts in phases I and II drug development for Crohn's Disease
Bằng: Jairath, V, et al.
Được phát hành: (2016) -
The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
Bằng: Sandborn, W, et al.
Được phát hành: (2016) -
Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease
Bằng: Jairath, V, et al.
Được phát hành: (2016) -
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
Bằng: D'Haens, G, et al.
Được phát hành: (2009) -
Biosimilars in IBD: hope or expectation?
Bằng: Gecse, K, et al.
Được phát hành: (2013)